01764nam a2200433 c 4500001001300000005001500013007000300028008004100031020002500072041001300097049002800110052001700138056001400155082001600169245029900185246006700484260005400551300004100605504002400646546002500670650003400695650004000729650004700769700002700816700005600843700005600899700002200955700002200977700002200999880008001021880005901101880002701160880002801187880002501215880002401240880002501264880002701289950001401316KMO20193645920190827154643ta190322s2018    tjkad         000   kor    a9788959704316g935100 akorbeng0 lEM7263885lEM7263886c201a518.31b19-1  a518.312601a615.321223006880-01a항암제 유발 골수억제 완화소재(HL314)의 비임상 연구 =xNonclinical study of HL314, a candidate for chemotherapy-induced myelosuppression :b2018년도 최종보고서 /d연구책임자: 김진희 ;e연구원: 방옥선,e김노수,e이진무,e신사라,e김영아30a항암제 유발 골수억제 완화소재의 비임상 연구  6880-02a대전 :b한국한의학연구원,c2018  avi, 51 p. :b삽화, 도표 ;c26 cm  a참고문헌: p. 49  a영어 요약 있음 8a생약[生藥]0KSH1998036146 8a항암제[抗癌劑]0KSH1998006358 8a임상 시험[臨床試驗]0KSH20020343811 6880-03a김진희4aut1 6880-04a방옥선,g方玉仙,d1960-0KAC2017139731 6880-05a김노수,g金老洙,d1969-0KAC2017329021 6880-06a이진무1 6880-07a신사라1 6880-08a김영아006245-01/(BaHangamje yubal golsu eokje wanhwa sojae(HL314)ui biimsang yeongu  6260-02/(BaDaejeon :bHanguk Hanuihak Yeonguwon,c20181 6700-03/(BaGim, Jinhui1 6700-04/(BaBang, Okseon1 6700-05/(BaGim, Nosu1 6700-06/(BaI, Jinmu1 6700-07/(BaSin, Sara1 6700-08/(BaGim, Yeonga1 a비매품